Explore

Rapid Read Rapid Read
Medical Microinstruments Gains FDA Clearance for Robotic Surgical Tools Enhancing Microsurgery Precision

Medical Microinstruments Gains FDA Clearance for Robotic Surgical Tools Enhancing Microsurgery Precision

Medical Microinstruments (MMI) has received FDA 510(k) clearance for its NanoWrist Scissors and Forceps, designed for soft tissue dissection in complex surgeries. These instruments are part of MMI's Symani Surgical System, which aids in procedures requiring extreme precision, such as lymphatic repair and cancer-related reconstructions. The first U.S. clinical use of these tools was conducted at Tampa General Hospital, where they were used in a lymphovenous bypass procedure. The instruments offer advanced features like motion scaling and tremor reduction, enhancing surgical precision beyond human capabilities.
Trendline Trendline
Digital Transformation in Healthcare: Alfred Olivares Discusses Affordability and Innovation

Digital Transformation in Healthcare: Alfred Olivares Discusses Affordability and Innovation

Digital Transformation in Healthcare: Alfred Olivares Discusses Affordability and Innovation
Trendline Trendline
a2z Radiology AI Secures $4.5M to Enhance CT Triage System

a2z Radiology AI Secures $4.5M to Enhance CT Triage System

a2z Radiology AI Secures $4.5M to Enhance CT Triage System
Rapid Read Rapid Read
Banner Health CEO Amy Perry Recognized Among Top Influential Healthcare Leaders

Banner Health CEO Amy Perry Recognized Among Top Influential Healthcare Leaders

Amy Perry, President and CEO of Banner Health, has been named to Modern Healthcare's list of the 100 Most Influential People in Healthcare for the second consecutive year. Since joining Banner Health in November 2021, Perry has been instrumental in positioning the organization as a leader in healthcare innovation and integration. Under her leadership, Banner Health has expanded its use of artificial intelligence and clinical research to improve health outcomes and access. The organization operates 33 hospitals and provides health insurance coverage to 1.2 million members across six states. Banner Health's commitment to community-centered care and its nonprofit mission have been key factors in its recognition. Perry's leadership has also been acknowledged through her inclusion in Modern Healthcare's Top 25 Women Leaders and Becker's Top 130 Women Healthcare Leaders to Know.
Rapid Read Rapid Read
Banner Health CEO Amy Perry Named Among 100 Most Influential in Healthcare

Banner Health CEO Amy Perry Named Among 100 Most Influential in Healthcare

Amy Perry, President and CEO of Banner Health, has been recognized by Modern Healthcare as one of the 100 Most Influential People in Healthcare for the second consecutive year. Since joining Banner Health in 2021, Perry has led the organization to become a model for future healthcare systems by integrating clinical excellence with advanced technology and financial strength. Banner Health, one of the largest nonprofit healthcare systems in the U.S., serves 3.5 million people annually across six states. Under Perry's leadership, the organization has expanded its use of artificial intelligence and clinical research to improve health outcomes and access.
Rapid Read Rapid Read
UK Doctors Develop Gene Therapy Offering Hope for Aggressive Blood Cancer Patients

UK Doctors Develop Gene Therapy Offering Hope for Aggressive Blood Cancer Patients

Doctors in the United Kingdom have pioneered a new gene therapy using base editing to treat aggressive blood cancers that were previously considered untreatable. The therapy has shown promising results, with the first patient experiencing a complete remission of leukemia after years of unsuccessful treatments. This breakthrough offers new hope for patients with similar diagnoses, potentially transforming the treatment landscape for aggressive blood cancers.
Rapid Read Rapid Read
New Research Links Social Media Use to Increased ADHD Symptoms in Children

New Research Links Social Media Use to Increased ADHD Symptoms in Children

A study conducted by the Karolinska Institute in Sweden and Oregon Health & Science University has found a significant correlation between social media use and increased symptoms of attention deficit hyperactivity disorder (ADHD) in children. The research followed 8,324 children aged nine to ten in the U.S. over four years, observing their social media usage and corresponding attention levels. The study revealed that children who increased their social media use from 30 minutes to 2.5 hours daily showed heightened inattention symptoms. The researchers noted that social media's constant distractions, such as notifications and messages, could impair children's ability to concentrate. The study did not find a similar link between ADHD symptoms and other screen activities like watching TV or playing video games.
Trendline Trendline
Novo Nordisk Faces Market Challenges Amidst GLP-1 Competition and Analyst Downgrades

Novo Nordisk Faces Market Challenges Amidst GLP-1 Competition and Analyst Downgrades

Novo Nordisk Faces Market Challenges Amidst GLP-1 Competition and Analyst Downgrades
Rapid Read Rapid Read
FDA Qualifies PathAI's AIM-MASH Tool, Revolutionizing MASH Clinical Trials

FDA Qualifies PathAI's AIM-MASH Tool, Revolutionizing MASH Clinical Trials

PathAI has achieved a significant milestone with the FDA qualification of its AIM-MASH AI Assist tool, marking it as the first AI-powered pathology biomarker to receive such status under the FDA's Drug Development Tool program. This follows a similar qualification from the European Medicines Agency, establishing AIM-MASH as the first tool with dual U.S. and EU regulatory recognition. The tool addresses variability in MASH clinical trials by standardizing liver biopsy scoring, thus reducing human variability and enabling more accurate enrollment and endpoint assessment.
Trendline Trendline
RxPost Wins Tech Competition with Innovative Pharmacy Marketplace

RxPost Wins Tech Competition with Innovative Pharmacy Marketplace

RxPost Wins Tech Competition with Innovative Pharmacy Marketplace
Trendline Trendline
Regeneron Advances Lynozyfic for Untreated Multiple Myeloma with Promising Study Results

Regeneron Advances Lynozyfic for Untreated Multiple Myeloma with Promising Study Results

Regeneron Advances Lynozyfic for Untreated Multiple Myeloma with Promising Study Results
Rapid Read Rapid Read
Sarah Ahmad Recognized for Transformative Leadership in Healthcare

Sarah Ahmad Recognized for Transformative Leadership in Healthcare

Sarah Ahmad, CEO of the Council for Affordable Quality Healthcare (CAQH), has been named one of Modern Healthcare’s 100 Most Influential People in Healthcare. Since taking the helm in 2023, Ahmad has spearheaded several initiatives that have significantly impacted the healthcare industry. Her leadership has been instrumental in securing partnerships with 12 major health plans, facilitating innovation and operational efficiency. Under her guidance, CAQH has achieved substantial financial gains, including hundreds of millions in customer savings through waste reduction. Ahmad has also focused on workforce development, implementing transparent career pathways and investing in employee growth. Her efforts have positioned CAQH as a leader in healthcare data management and process improvement.